Diana DeGette

The approval of new drugs and medical devices is a process fraught with scientific, political, and ethical landmines. Inherent in any such process is an unavoidable conflict between rigorous science and safety on the one side, which tend to slow the process down by requiring large randomized clinical trials that can take years, versus forces that demand faster approval. For example, patients suffering from deadly diseases demand faster approval of drugs that might give them the hope of surviving their disease, or at least of surviving considerably longer. This is a powerful force for reform,…
Now that we're solidly into 2015, it's a good time to check in on what the legislative priorities are going to be among various advocates of quackery and "health freedom" (but I repeat myself). There's a new Republican Congress, and a lot of chairmanships are going to be reshuffled, with various legislators finding themselves in control of important Congressional committees. Fortunately for us, one of the major promoters of "health freedom" (or, as I like to call it, the freedom of quacks from pesky government laws and regulations), has laid out exactly what its priorities are for 2015.…